TR201619954A2 - Oftalmi̇k farmasöti̇k bi̇leşi̇mler - Google Patents

Oftalmi̇k farmasöti̇k bi̇leşi̇mler Download PDF

Info

Publication number
TR201619954A2
TR201619954A2 TR2016/19954A TR201619954A TR201619954A2 TR 201619954 A2 TR201619954 A2 TR 201619954A2 TR 2016/19954 A TR2016/19954 A TR 2016/19954A TR 201619954 A TR201619954 A TR 201619954A TR 201619954 A2 TR201619954 A2 TR 201619954A2
Authority
TR
Turkey
Prior art keywords
pharmaceutical compositions
ophthalmic pharmaceutical
ocular hypertension
glaucoma
symptomatic
Prior art date
Application number
TR2016/19954A
Other languages
English (en)
Inventor
Karaağaç Esra
Original Assignee
Esra Karaagac
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esra Karaagac filed Critical Esra Karaagac
Priority to TR2016/19954A priority Critical patent/TR201619954A2/tr
Publication of TR201619954A2 publication Critical patent/TR201619954A2/tr

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş, glokom, oküler hipertansiyon, açık açılı glokom ve oküler hipertansiyonu olan hastalarda artmış intraokuler basıncı düşürmenin profilaktik ve/veya semptomatik ve/veya terapötik tedavisinde kullanılmak üzere prostaglandin analoğu olan etken maddeyi ve/veya farmasötik olarak kabul edilebilir türevlerini içeren farmasötik bileşim/ler ile ilgilidir.
TR2016/19954A 2016-12-28 2016-12-28 Oftalmi̇k farmasöti̇k bi̇leşi̇mler TR201619954A2 (tr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2016/19954A TR201619954A2 (tr) 2016-12-28 2016-12-28 Oftalmi̇k farmasöti̇k bi̇leşi̇mler

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2016/19954A TR201619954A2 (tr) 2016-12-28 2016-12-28 Oftalmi̇k farmasöti̇k bi̇leşi̇mler

Publications (1)

Publication Number Publication Date
TR201619954A2 true TR201619954A2 (tr) 2018-07-23

Family

ID=64901186

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2016/19954A TR201619954A2 (tr) 2016-12-28 2016-12-28 Oftalmi̇k farmasöti̇k bi̇leşi̇mler

Country Status (1)

Country Link
TR (1) TR201619954A2 (tr)

Similar Documents

Publication Publication Date Title
PH12019500423A1 (en) Pharmaceutical composition
EA201790889A1 (ru) Офтальмологический раствор
MX2020009132A (es) Composiciones farmaceuticas que comprenden nebivolol.
WO2018033792A3 (en) Ophthalmic pharmaceutical compositions and uses relating thereto
WO2019209955A3 (en) Use of pilocarpine hydrochloride for the treatment of ocular conditions
MX2020003534A (es) Composiciones oftalmicas que comprenden latanoprost para usarse en el tratamiento de las enfermedades oculares.
JP2018531233A5 (tr)
EA201071413A1 (ru) Способ и композиция для лечения повышения внутриглазного давления и глаукомы
CL2020002252A1 (es) Formulación oftálmica.
MX2019013799A (es) Peptido novedoso y composicion farmaceutica para tratar una enfermedad ocular que comprende el mismo como un ingrediente farmaceutico activo.
MX391627B (es) Aplicación cuantitativa periorbital de fármacos oftalmológicos.
SG11202008901WA (en) Ophthalmic compositions, and ocular uses thereof, of indigo carmine
AU2017261303A1 (en) Ophthalmic compositions
MX2024003580A (es) Metodos de tratamiento de enfermedades inflamatorias oculares.
EP4338751A3 (en) Medicament comprising combination of sepetaprost and rho-associated coiled-coil containing protein kinase inhibitor
PH12012501271A1 (en) Topical ophthalmic peptide formulation
EA201891730A1 (ru) Офтальмологическая композиция для применения при лечении офтальмологических расстройств, связанных с изменениями роговично-конъюнктивальной поверхности
CY1124930T1 (el) Διεργασια για την παρασκευη στειρων οφθαλμικων υδατικων εναιωρηματων νανοκρυσταλλων μορφης α προπιονικης φλουτικαζονης
MA40847A (fr) Association comprenant de la spiruline et du palmitoyléthanolamide et/ou des sels ou des dérivés pharmaceutiquement acceptables de ceux-ci et leurs formulations, pour une utilisation dans la prévention et/ou le traitement d'états d'hyperactivité des tissus
PH12020550722A1 (en) Ophthalmic topical composition comprising dobesilic acid for treating diseases of the posterior segment of the eye
EP4559529A3 (en) Isocyclosporin a for topical treatment of ocular diseases
GR1008511B (el) Οφθαλμικο φαρμακευτικο σκευασμα ελευθερο συντηρητικου περιεχον τραβοπροστη και τιμολολη
EA202091543A1 (ru) Комбинация омиденепага
BR112017021374A2 (pt) ácido pirrolidona carboxílico (pca) para uso oftálmico
MX2022006523A (es) Composicion que comprende budesonida para uso oftalmico.